158 related articles for article (PubMed ID: 36853386)
1. Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships.
Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
Eur J Clin Pharmacol; 2023 Apr; 79(4):553-567. PubMed ID: 36853386
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients.
Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective medication adherence in Western Australians in the first year after myocardial infarction: restricted cubic spline analysis of adherence-outcome relationships.
Greenland M; Knuiman MW; Hung J; Nedkoff L; Arnet I; Rankin JM; Kilkenny MF; Sanfilippo FM
Sci Rep; 2020 Mar; 10(1):4315. PubMed ID: 32152400
[TBL] [Abstract][Full Text] [Related]
4. Comparison of medication adherence measures derived from linked administrative data and associations with mortality using restricted cubic splines in heart failure patients.
Qin X; Hung J; Knuiman MW; Briffa TG; Teng TK; Sanfilippo FM
Pharmacoepidemiol Drug Saf; 2020 Feb; 29(2):208-218. PubMed ID: 31958191
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based pharmacotherapies used in the postdischarge phase are associated with improved one-year survival in senior patients hospitalized with heart failure.
Qin X; Hung J; Knuiman M; Teng TK; Briffa T; Sanfilippo FM
Cardiovasc Ther; 2018 Dec; 36(6):e12464. PubMed ID: 30126048
[TBL] [Abstract][Full Text] [Related]
6. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020.
Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S
ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969
[TBL] [Abstract][Full Text] [Related]
7. Treatment Initiation Patterns, Modifications, and Medication Adherence Among Newly Diagnosed Heart Failure Patients: A Retrospective Claims Database Analysis.
Deschaseaux C; McSharry M; Hudson E; Agrawal R; Turner SJ
J Manag Care Spec Pharm; 2016 May; 22(5):561-71. PubMed ID: 27123917
[TBL] [Abstract][Full Text] [Related]
8. Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.
Lu L; Jackevicius CA; de Leon NK; Warner AL; Chang DS; Mody FV
Clin Ther; 2017 Jun; 39(6):1200-1209. PubMed ID: 28545803
[TBL] [Abstract][Full Text] [Related]
9. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.
Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G
J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181
[TBL] [Abstract][Full Text] [Related]
10. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; DeVore AD; Lu D; Madden G; Bhatt DL; Schulte PJ; Heidenreich PA; Yancy CW; Hernandez AF; Fonarow GC
JACC Heart Fail; 2016 Aug; 4(8):649-61. PubMed ID: 27179827
[TBL] [Abstract][Full Text] [Related]
11. The effect of evidence-based medication use on long-term survival in patients hospitalised for heart failure in Western Australia.
Teng TH; Hung J; Finn J
Med J Aust; 2010 Mar; 192(6):306-10. PubMed ID: 20230346
[TBL] [Abstract][Full Text] [Related]
12. Projected Clinical Benefits of Implementation of SGLT-2 Inhibitors Among Medicare Beneficiaries Hospitalized for Heart Failure.
Vaduganathan M; Greene SJ; Zhang S; Solomon N; Chiswell K; Devore AD; Butler J; Heidenreich PA; Huang JC; Kittleson MM; Joynt Maddox KE; Mcdermott JJ; Owens AT; Peterson PN; Solomon SD; Vardeny O; Yancy CW; Fonarow GC
J Card Fail; 2022 Apr; 28(4):554-563. PubMed ID: 34785402
[TBL] [Abstract][Full Text] [Related]
13. Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients.
Scalvini S; Bernocchi P; Villa S; Paganoni AM; La Rovere MT; Frigerio M
Int J Cardiol; 2021 May; 330():106-111. PubMed ID: 33582198
[TBL] [Abstract][Full Text] [Related]
14. Comparative Outcomes of Sacubitril/Valsartan Use After Hospitalization for Heart Failure Among Medicare Beneficiaries Naïve to Renin-Angiotensin System Inhibitors.
Pierce JB; Blumer V; Choi S; Hardy NC; Greiner MA; Carnicelli AP; Shen X; Lippmann SJ; Peterson PN; Allen LA; Fonarow GC; Mentz RJ; Greene SJ; O'Brien EC
Am J Cardiol; 2023 Oct; 204():151-158. PubMed ID: 37544137
[TBL] [Abstract][Full Text] [Related]
15. Adherence to heart failure management medications following cardiac resynchronization therapy.
Shah BR; DerSarkissian M; Tsintzos SI; Xiao Y; May D; Lu X; Kinrich D; Davis E; Lefebvre P; Duh MS; Dasta JF
Curr Med Res Opin; 2020 Feb; 36(2):199-207. PubMed ID: 31535559
[No Abstract] [Full Text] [Related]
16. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
[TBL] [Abstract][Full Text] [Related]
17. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Thomas J; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012721. PubMed ID: 29952095
[TBL] [Abstract][Full Text] [Related]
19. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.
Martin N; Manoharan K; Davies C; Lumbers RT
Cochrane Database Syst Rev; 2021 May; 5(5):CD012721. PubMed ID: 34022072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
